{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:27:01Z","timestamp":1791282421443,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007963.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T00:00:00Z","timestamp":1512172800000}}],"reference-count":80,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007963.pub3","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T10:42:17Z","timestamp":1512384137000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Oxcarbazepine for neuropathic pain"],"prefix":"10.1002","volume":"2017","author":[{"given":"Muke","family":"Zhou","sequence":"first","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Chen","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"He","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Yang","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cairong","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Public Health, Sichuan University; Epidemic Disease & Health Statistics Department; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengbo","family":"Wu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Pharmacy; No. 37, Guo Xue Xiang Chengdu Sichuan China 60041"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,12,2]]},"reference":[{"key":"10.1002\/14651858.CD007963.pub3-BIB0003|cit1","unstructured":"Multicenter, double-blind, randomized placebo-control, parallel group study to evaluate the safety and efficacy of three doses of oxcarbazepine in patients with neuropathic pain due to diabetic neuropathy, 2003 www.novctrd.com\/CtrdWeb\/product.nov?diseaseid=141&productid=330"},{"issue":"6","key":"10.1002\/14651858.CD007963.pub3-BIB0001|cit2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0404.2006.00631.x","article-title":"Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study","volume":"113","author":"Beydoun","year":"2006","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0002|cit3","first-page":"101","article-title":"Results of a randomized, placebo-controlled trial suggest oxcarbazepine has a therapeutic effect in the treatment of painful diabetic neuropathy","volume":"11 Suppl 2","author":"Beydoun","year":"2004","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0005|cit4","unstructured":"Oxcarbazepine for the treatment of chronic peripheral neuropathic pain (IMIOXC) https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT01302275?term=NCT01302275&rank=1"},{"issue":"11","key":"10.1002\/14651858.CD007963.pub3-BIB0004|cit5","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.pain.2014.08.014","article-title":"The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study","volume":"155","author":"Demant","year":"2014","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0009|cit6","unstructured":"Multicenter, double-blind, randomized placebo-control, parallel-group study to evaluate the safety and efficacy of oxcarbazepine in patients with neuropathic pain due to diabetic neuropathy, 2005 www.novctrd.com\/CtrdWeb\/product.nov?diseaseid=141&productid=330"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD007963.pub3-BIB0006|cit7","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jpain.2004.02.560","article-title":"Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study","volume":"5","author":"Dogra","year":"2004","journal-title":"Journal of Pain"},{"issue":"5","key":"10.1002\/14651858.CD007963.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejpain.2004.11.006","article-title":"Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study","volume":"9","author":"Dogra","year":"2005","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0007|cit9","first-page":"92","article-title":"Oxcarbazepine provides pain relief in patients with painful diabetic neuropathy: a randomized, placebo-controlled study","volume":"11 Suppl 2","author":"Dogra","year":"2004","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0011|cit10","unstructured":"Multicenter, double-blind, randomized, placebo-control, parallel study to evaluate the safety and efficacy of oxcarbazepine in patients with neuropathic pain due to diabetic neuropathy, 2003 www.novctrd.com\/CtrdWeb\/product.nov?diseaseid=141&productid=330"},{"issue":"3","key":"10.1002\/14651858.CD007963.pub3-BIB0010|cit11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0404.2005.00559.x","article-title":"A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy","volume":"114","author":"Grosskopf","year":"2006","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0012|cit12","first-page":"101","article-title":"Oxcarbazepine in the treatment of painful diabetic neuropathy: a randomized, placebo-controlled study","volume":"11 Suppl 2","author":"Riviere","year":"2004","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0014|cit13","unstructured":"Multicenter, double-blind, randomized, placebo-control, parallel-group study to evaluate the safety and efficacy of oxcarbazepine in patients with neuropathic pain due to radiculopathy, 2005 www.novctrd.com\/CtrdWeb\/product.nov?diseaseid=429&productid=330"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0013|cit14","first-page":"A120","article-title":"Efficacy and safety of oxcarbazepine in patients with neuropathic pain due to radiculopathy: a double-blind, randomized, placebo-controlled study","volume":"64 Suppl 1","author":"Harden","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s10194-015-0563-z","article-title":"Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP)","volume":"16","author":"Besi","year":"2015","journal-title":"Journal of Headache and Pain"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0016|cit16","first-page":"A471","article-title":"Oxcarbazepine versus carbamazepine in patients with new onset trigeminal neuralgia result of double blind comparative trial [abstract no.P06.116]","volume":"58 Suppl 3","author":"Beydoun","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD007963.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-0404.2006.00710.x","article-title":"Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy","volume":"115","author":"Beydoun","year":"2007","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0018|cit18","unstructured":"Brainer-Lima P Naylor F Oxcarbazepine for cancer-related neuropathic pain and opiate detoxification 22nd Annual Meeting of the American Pain Society; 2003 March 20-23; Chicago (IL) 2003"},{"issue":"12","key":"10.1002\/14651858.CD007963.pub3-BIB0019|cit19","first-page":"74","article-title":"A randomised controlled trial of 3 drugs for the treatment of idiopathic trigeminal neuralgia","volume":"2","author":"Gong","year":"2010","journal-title":"Journal of China Traditional Chinese Medicine Information"},{"issue":"25","key":"10.1002\/14651858.CD007963.pub3-BIB0020|cit20","first-page":"107","article-title":"The comparative efficacy of oxcarbazepine and carbamazepine for trigeminal neuralgia","volume":"50","author":"Hu","year":"2010","journal-title":"Shandong Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD007963.pub3-BIB0021|cit21","first-page":"167","article-title":"Clinical efficacy of oxcarbazepine for\u00a0primary trigeminal neuralgia","volume":"21","author":"Li","year":"2011","journal-title":"Zhejiang Journal of Integrated Traditional Chinese and Western Medicine"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0022|cit22","first-page":"S5","article-title":"Results of a double-blind trial comparing oxcarbazepine (OXC) vs carbamazepine (CBZ) in newly diagnosed, untreated patients with trigeminal neuralgia","volume":"187 Suppl 1","author":"Liebel","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/0304-3959(87)91248-6","article-title":"The analgesic effect of carbamazepine in trigeminal neuralgia","volume":"28 Suppl 4","author":"Lindstr\u00f6m","year":"1987","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0025|cit24","unstructured":"Symptom-based treatment for neuropathic pain in spinal cord injured patients, randomized clinical trial, 2014 clinicaltrials.gov\/ct2\/show\/study\/NCT02180880?term=oxcarbazepine&rank=34"},{"issue":"5","key":"10.1002\/14651858.CD007963.pub3-BIB0024|cit25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/PHM.0000000000000382","article-title":"Symptom-based treatment of neuropathic pain in spinal cord-injured patients: a randomized crossover clinical trial","volume":"95","author":"Min","year":"2016","journal-title":"American Journal of Physical Medicine & Rehabilitation"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1111\/j.1528-1157.1994.tb05946.x","article-title":"Oxcarbazepine and intractable trigeminal neuralgia","volume":"35 Suppl 3","author":"R\u00e9millard","year":"1994","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD007963.pub3-BIB0027|cit27","first-page":"129","article-title":"Comparison of oxcarbazepine and gabapentin at standard dose in treatment of pain for postherpetic neuropathy","volume":"27","author":"Venancio-Ramirez","year":"2004","journal-title":"Revista Mexicana de Anestesiologia"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0028|cit28","first-page":"89","article-title":"A clinical research on the pharmacological treatment of trigeminal neuralgia","volume":"1","author":"Zhou","year":"2010","journal-title":"Medical Information Operations Sciences Fascicule"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0029|cit29","unstructured":"NCT02219373 Gabapentin and oxcarbazepine for chronic neuropathic pain in children and adolescents: a clinical effectiveness study clinicaltrials.gov\/ct2\/show\/NCT02219373"},{"issue":"11","key":"10.1002\/14651858.CD007963.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"European Journal of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD007963.pub3-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1468-1311.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2009 revision","volume":"17","author":"Attal","year":"2010","journal-title":"European Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD007963.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","article-title":"Gabapentin dosing for neuropathic pain: evidence from randomized placebo-controlled clinical trials","volume":"25","author":"Backonja","year":"2003","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0033|cit33","first-page":"A131","article-title":"Oxcarbazepine versus carbamazepine in trigeminal neuralgia: a meta-analysis of three double-blind comparative trials","volume":"58 Suppl 3","author":"Beydoun","year":"2002","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0034|cit34","unstructured":"Beydoun A Schmidt D D'Souza J on behalf of the oxcarbazepine study group Meta-analysis of comparative trials of oxcarbazepine versus carbamazepine in trigeminal neuralgia 21st American Pain Society Annual Meeting; 2002 Mar 14-17; Baltimore (MD)"},{"issue":"2","key":"10.1002\/14651858.CD007963.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3959(90)90018-9","article-title":"The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation and preliminary investigation for ratio scale properties","volume":"41","author":"Bieri","year":"1990","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD007963.pub3-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009485.pub2","article-title":"Phenytoin for neuropathic pain and fibromyalgia in adults","author":"Birse","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD007963.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/bjaceaccp\/mkn037","article-title":"Assessment of neuropathic pain","volume":"8","author":"Callin","year":"2008","journal-title":"Continuing Education in Anaesthesia, Critical Care and Pain"},{"issue":"2","key":"10.1002\/14651858.CD007963.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.tpj.6500095","article-title":"Molecular aspects of pain research","volume":"2","author":"Carpenter","year":"2002","journal-title":"Pharmacogenomics Journal"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD007963.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0885-3924(03)00067-8","article-title":"Rationale and evidence for the use of oxcarbazepine in neuropathic pain","volume":"25","author":"Carrazana","year":"2003","journal-title":"Journal of Pain and Symptom Management"},{"issue":"5","key":"10.1002\/14651858.CD007963.pub3-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009486.pub2","article-title":"Clonazepam for neuropathic pain and fibromyalgia in adults","author":"Corrigan","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007963.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0404.2005.00300.x","article-title":"Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin","volume":"111","author":"Criscuolo","year":"2005","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD007963.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0920-1211(89)90070-3","article-title":"A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy","volume":"3","author":"Dam","year":"1989","journal-title":"Epilepsy Research"},{"issue":"2","key":"10.1002\/14651858.CD007963.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/104990910402100213","article-title":"Epidemiology of cancer pain and factors influencing poor pain control","volume":"21","author":"Davis","year":"2004","journal-title":"American Journal of Hospice and Palliative Care"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0044|cit44","unstructured":"Deeks JJ Higgins JPT Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1129-2377-15-34","article-title":"Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain","volume":"15","author":"Stefano","year":"2014","journal-title":"Journal of Headache and Pain"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/eujp.2001.0323","article-title":"Neurobiology of neuropathic pain: mode of action of anticonvulsants","volume":"6 Suppl A","author":"Dickenson","year":"2002","journal-title":"European Journal of Pain"},{"issue":"9","key":"10.1002\/14651858.CD007963.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2165\/00003495-200767090-00003","article-title":"Antiepileptic drugs in the treatment of neuropathic pain","volume":"67","author":"Eisenberg","year":"2007","journal-title":"Drugs"},{"issue":"1","key":"10.1002\/14651858.CD007963.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1472-8206.2007.00474.x","article-title":"Chronic neuropathic pain: mechanisms, drug targets and measurement","volume":"21","author":"Finnerup","year":"2007","journal-title":"Fundamental Clinical Pharmacology"},{"issue":"13","key":"10.1002\/14651858.CD007963.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMe030014","article-title":"Opioids and chronic neuropathic pain","volume":"348","author":"Foley","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD007963.pub3-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009183.pub2","article-title":"Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults","author":"Gill","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0051|cit51","unstructured":"GRADE Working Group, McMaster University GRADEpro 2008"},{"issue":"3","key":"10.1002\/14651858.CD007963.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jech.41.3.251","article-title":"Lumbar disc syndrome in Finland","volume":"41","author":"Heliovaara","year":"1987","journal-title":"Journal of Epidemiology and Community Health"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0053|cit53","unstructured":"Higgins JPT Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0054|cit54","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0055|cit55","unstructured":"Higgins JPT Deeks JJ Altman DG Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD007963.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.coi.2012.10.002","article-title":"Human leukocyte antigen-associated drug hypersensitivity","volume":"25","author":"Illing","year":"2013","journal-title":"Current Opinion in Immunology"},{"issue":"1-3","key":"10.1002\/14651858.CD007963.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(01)01302-4","article-title":"The clinical picture of neuropathic pain","volume":"429","author":"Jensen","year":"2001","journal-title":"European Journal of Pharmacology"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/eujp.2001.0324","article-title":"Anticonvulsants in neuropathic pain: rationale and clinical evidence","volume":"6 Suppl A","author":"Jensen","year":"2002","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/0304-3959(87)91248-6","article-title":"The analgesic effect of carbamazepine in trigeminal neuralgia","volume":"30","author":"Lindstrom","year":"1987","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD007963.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s10072-005-0464-z","article-title":"Oxcarbazepine is effective and safe in the treatment of neuropathic pain: pooled analysis of seven clinical studies","volume":"26","author":"Magenta","year":"2005","journal-title":"Neurological Sciences"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0061|cit61","volume-title":"Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms","author":"Merskey","year":"1994"},{"issue":"3","key":"10.1002\/14651858.CD007963.pub3-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007963.pub3-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub3","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD007963.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1517\/13543784.16.10.1615","article-title":"Oxcarbazepine in neuropathic pain","volume":"16","author":"Nasreddine","year":"2007","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0065|cit65","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0066|cit66","unstructured":"Ryan R Hill S Cochrane Consumers and Communication Group How to GRADE the quality of the evidence, Version 1.0, June 2016 cccrg.cochrane.org\/author-resources"},{"issue":"6","key":"10.1002\/14651858.CD007963.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00002508-200211000-00002","article-title":"Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy","volume":"18","author":"Schmader","year":"2002","journal-title":"Clinical Journal of Pain"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0068|cit68","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007963.pub3-BIB0069|cit69","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"12","key":"10.1002\/14651858.CD007963.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tips.2004.10.002","article-title":"Bad news from the brain: descending 5-HT pathways that control spinal pain processing trends","volume":"25","author":"Suzuki","year":"2004","journal-title":"Trends in Pharmacological Sciences"},{"issue":"18","key":"10.1002\/14651858.CD007963.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD007963.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200519040-00005","article-title":"HIV-associated neuropathic pain: epidemiology, pathophysiology and management","volume":"19","author":"Verma","year":"2005","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1002\/14651858.CD007963.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"issue":"12","key":"10.1002\/14651858.CD007963.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/sj.sc.3101641","article-title":"Neuropathic pain after traumatic spinal cord injury? Relations to gender, spinal level, completeness, and age at the time of injury","volume":"42","author":"Werhagen","year":"2004","journal-title":"Spinal Cord"},{"issue":"1","key":"10.1002\/14651858.CD007963.pub3-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001133.pub3","article-title":"WITHDRAWN: Anticonvulsant drugs for acute and chronic pain","author":"Wiffen","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD007963.pub3-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006044.pub4","article-title":"Lamotrigine for chronic neuropathic pain and fibromyalgia in adults","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007963.pub3-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005451.pub3","article-title":"Carbamazepine for chronic neuropathic pain and fibromyalgia in adults","author":"Wiffen","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD007963.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2702.2005.01121.x","article-title":"Pain: a review of three commonly used pain rating scales","volume":"14","author":"Williamson","year":"2005","journal-title":"Journal of Clinical Nursing"},{"issue":"3","key":"10.1002\/14651858.CD007963.pub3-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007963","article-title":"Oxcarbazepine for neuropathic pain","author":"Zhou","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007963.pub3-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007963.pub2","article-title":"Oxcarbazepine for neuropathic pain","author":"Zhou","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007963.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T10:32:01Z","timestamp":1643020321000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007963.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,2]]},"references-count":80,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007963.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,2]]}}}